Emergency icon Important Updates
Department Endocrinology and Metabolism Institute
Primary Location Cleveland Clinic Main Campus
Type of Doctor Adults Only
Languages English, Portuguese, Spanish
Surgeon No
Cleveland Clinic Main Campus
Primary Location

Cleveland Clinic Main Campus


Additional Locations

Specialties & Treatments

Treatment & Services

  • Medical Weight Management
View all 1 Treatment & Services +


Is Cleveland Clinic Part of Your Insurance?

Review a list of accepted insurance plans for our Northeast Ohio locations or learn more about purchasing a contracted managed care plan.

View All Plans

About Bartolome Burguera, MD, PhD

Bartolome Burguera M.D, Ph.D. is Chairman of Endocrinology and Metabolism Institute (EMI). He joined the Cleveland Clinic as staff physician and Director of Obesity programs in the Department of Endocrinology Metabolic Institute and the Bariatric Institute, on September of 2013. He is also Professor of Medicine in the Cleveland Clinic Lerner College of Medicine and has a joint appointment in the department of Cellular & Molecular Medicine.

He also serves as Executive Medical Director of the National Diabetes and Obesity Research Institute in Biloxi, Mississippi. A scientific and educational collaboration between the state of Mississippi, prominent medical and academic Mississippian institutions and the Cleveland clinic.

His clinical and academic interests are focused on the field of obesity, particularly the role of bariatric medicine and non-surgical weight-loss interventions to treat obesity and diabetes. He has also studied the prevention of childhood obesity. He has been very instrumental setting up a large interdisciplinary shared medical appointment obesity therapeutic program, which is being offered face-to-face as well as through virtual visits.

Dr. Burguera was at the forefront of research around medical treatment for obesity and the role of leptin in the regulation of appetite in the early 1990s. He collaborated in major international obesity prevention and therapy initiatives and helped develop obesity programs at various institutions, working as a fellow at Mayo Clinic, and as a staff consultant at Boston University, University of Pittsburgh and Son Dureta University Hospital in Spain. He had the opportunity of working at East Carolina University when the bypass surgery was being developed, as a potential treatment for obesity and diabetes. He was also responsible for setting up the clinical trial TRAMOMTANA which demonstrated the positive role of an intensive life style intervention and medications, as medical therapy of patients with severe obesity who are non-surgical candidates. He is also interested in obesity prevention in children. He was responsible for a program named ACTYBOSS, an Obesity prevention clinical trial, incentive-driven, after-school intervention program which involved free supervised exercise sessions and nutritional lectures.

He has served as a principal investigator, co-investigator on several federal and pharmaceutical funded projects, focusing on obesity therapy, both in the US and in Spain. He has published more than 100 articles and book chapters in the field of obesity and was the recipient of the 2018 “Novoa Santos Award,” one the most prestigious medical recognitions in Spain. He is currently the Principal Investigator of a large clinical trial evaluating the role of anti-obesity medication in the context of share medical appointments.Dr. Burguera is active in community affairs, and is participating in several life style intervention and obesity prevention initiatives both in adults and children (ACTiVHOS) in the Cleveland area.

In this role as EMI Chair, Dr. Burguera oversees more than 130 employees, including 42 staff endocrinologist, 5 endocrine surgeons and 20 nurse practitioners, located on the Main Campus and throughout the Cleveland Clinic Enterprise. The institute is dedicated to medical and surgical conditions of the endocrine system, including diabetes, thyroid, metabolism, pituitary, adrenal, and obesity. It integrates both the department of Endocrinology, Diabetes and Metabolism and the department of Endocrine Surgery. 

Dr, Burguera earned his medical degree from the University of Santiago (Spain). He also holds a PhD evaluating the role of glucocorticoid on the neuro-regulation of growth hormone secretion. He later completed research fellowships at East Carolina University and the National Institutes of Health. In 1996, he completed his residency in Internal Medicine at Norwalk Hospital, Norwalk, Conn., and in 1999, he completed a fellowship in endocrinology at Mayo Clinic.

Education & Professional Highlights

Education & Professional Highlights


Education & Fellowships

Fellowship - Mayo Clinic
Rochester, MN USA

Residency - Norwalk Hospital
Internal Medicine
Norwalk, CT USA

Medical Education - Universidad de Santiago de Compostela-Facultad de Medicina
Sp Spain


  • Internal Medicine - Endocrinology, Diabetes and Metabolism

Specialty Interests

Life Style Interventions, Obesity, Type 2 Diabetes, Diabetes Mellitus, Bariatric Medicine

Research & Publications

Research & Publications

See publications for Bartolome Burguera, MD, PhD.

(Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)

Industry Relationships

Industry Relationships

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 3/12/2023, Dr. Burguera has reported the financial relationships with the companies listed below. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.

Patient Satisfaction Reviews

55 Patient Satisfaction Reviews

The Patient Satisfaction Rating is an average of all responses to the care provider related questions shown below from our nationally-recognized Press Ganey Patient Satisfaction Survey. Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.

Responses are measured on a scale of 1 to 5 with 5 being the best score.

The comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Cleveland Clinic.

Overall Star Ratings
4.8 out of 5
Explains 4.8
Courtesy, Respect & Concern 4.9
Patient Rating of Doctor 4.8

8 Patient Comments

Reviewed on Apr 29, 2024

I was extremely impressed with the doctors efforts to personalize our discussion.

Reviewed on Apr 1, 2024

Dr. Burguera was very kind and patient with me. He takes the time that I need and answers all my questions.

Reviewed on Apr 1, 2024

I would definitely recommend Dr. Burguera

Reviewed on Apr 1, 2024

Clearly one of the finest physician at the Clunic

Reviewed on Mar 4, 2024

Dr is the best! He cares, helps and explains.

Reviewed on Jan 8, 2024

I feel so fortunate to have found this doctor and a very hopeful about treatment. I felt very much that he listened and took an interest in my situation. Thank you.

Reviewed on Aug 14, 2023

Outstanding doctor in every way!

Reviewed on Jun 19, 2023

Dr. Buguera demonstrates compassion, empathy, and professionalism.

Back to Top